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Abbreviations 
AF: preoperative atrial fibrillation 
BITA: Bilateral internal thoracic artery  
BMI: body mass index 
CABG: coronary artery bypass grafting  
CCS: Canadian Cardiovascular Society 
COPD: chronic obstructive pulmonary disease 
CVA: cerebrovascular accident  
CX: circumflex artery  
DIA: Diagonal branch 
DM-I: diabetes mellitus on insulin  
DM-O: diabetes mellitus on oral treatment  
EF: ejection fraction 
IABP: need for postoperative intra-aortic balloon pump 
LAD: left anterior descending artery  
LMD: left main disease 
LITA: left internal thoracic artery  
LV: left ventricle 
MI: myocardial infarction;  
NYHA: New York Heart Association 
OPCAB: off-pump coronary artery bypass   
PCI: percutaneous coronary intervention  
PSM: Propensity score matching 
PVD: peripheral vascular disease 
RA: radial artery 
RCA: right coronary artery  
RITA: right internal thoracic artery  
RRT: postoperative replacement therapy 
SV: saphenous vein 
Central picture 
Long term survival in patients receiving radial artery or saphenous vein in the context 
of bilateral internal thoracic artery grafting (BITA: Bilateral internal thoracic artery; RA: 
radial artery; SV: saphenous vein).  
Central message 
Long term survival in the context of bilateral internal thoracic artery grafting is not 
extended by using the radial artery in preference to saphenous vein in select low 
risk patients.   
Perspective statement  
Long term survival in the context of bilateral internal thoracic artery grafting is not 
extended by using the radial artery as the third arterial conduit in preference to 
saphenous vein also in select low risk patients. More data are needed before it is 
clear whether vein graft should be preferred as third conduit in this setting.  
Abstract 
Objective: Whether the use of the radial artery (RA) as third arterial conduit in addition 
to bilateral internal thoracic artery (BITA) is associated with better survival when 
compared to BITA plus saphenous vein (SV) remains to be determined. Methods: 
The study population included a select low risk group of 275 subjects who received 
BITA grafting with the RA as third arterial conduit (BITA+RA group) and 489 subjects 
who received BITA grafting with additional SV graft (BITA+SV). The RA was 
considered only in case of target stenosis ≥75%. We finally obtained 275 propensity 
score matched pairs for comparison.  
Results: Operative mortality was 1(0.3%) and 2(0.7%) in the BITA+RA and BITA+SV 
groups respectively (P=0.56). After a mean follow-up time of 10.6±4.8 years the 
BITA+RA group the survival probability at 5, 10 and 15 years was 97.4±0.9%, 
90.3±2.0% and 81.7±3.2% versus 97.0±1.0%, 94.1±1.5% and 82.1±3.4% (log-rank 
P=0.54, HR 1.16;95%CI 0.71-1.9). The two strategies showed comparable survival 
probabilities when RAs or SVs were used to graft the right coronary system only 
(P=0.79) or the left coronary system only (P=0.55). The lack of survival advantage in 
the BITA+RA group was confirmed in patients aged 60 or less (P=0.80) or aged more 
than 60 (P=0.53), in patients with and without diabetes mellitus (P=0.89 and P=0.54 
respectively) and with or without left ventricular dysfunction (P=0.95 and P=0.65 
respectively).   
Conclusions: Long term survival in a select low risk group of patients receiving 
BITA grafting was not extended by using the RA as the third arterial conduit in 
preference to SV.  
Word count: 248  
Late survival after coronary artery bypass graft (CABG) surgery is improved when the 
left internal thoracic artery (LITA) is grafted to the left anterior descending (LAD) 
coronary artery [1]. The right internal thoracic artery (RITA) has been advocated to 
further improve long term revascularization outcomes [2]. Whether the use of the radial 
artery (RA) [3-5] as third arterial conduit in addition to bilateral internal thoracic artery 
(BITA) grafting is associated with better survival when compared to BITA plus 
saphenous vein (SV) remains to be determined with isolated small series reporting 
conflicting results [6,7].  
Propensity score matching (PSM) based analyses are emerging as an attractive 
alternative in view of paucity of evidence from randomized controlled trials [8]. To 
investigate the impact of using the RA as third conduit instead of SV in the context of 
BITA grafting, we performed a single centre long term PSM comparison.  
 
Methods 
The study was conducted in accordance with the principles of the Declaration of 
Helsinki. The local audit committee approved the study, and the requirement for 
individual patient consent was waived. We retrospectively analysed prospectively 
collected data from The National Institute for Cardiovascular Outcomes Research 
(NICOR) NACSA registry on 1 June 2015 for all isolated first time CABG procedures 
performed at the Bristol Heart Institute, Bristol United Kingdom from 1996 to April 
2015.  Reproducible cleaning algorithms were applied to the database, which are 
regularly updated as required. Briefly, duplicate records and non-adult cardiac surgery 
entries were removed; transcriptional discrepancies harmonized; and clinical conflicts 
and extreme values corrected or removed. The data are returned regularly to the local 
units for validation.  
Further details and definition of variables are available at 
http://www.ucl.ac.uk/nicor/audits/adultcardiac/datasets. Among 12247 isolated first 
time CABG cases performed at our institution during the study period, we selected 
subjects who met the following criteria: multivessel coronary disease including left 
main and/or LAD disease; requiring at least 3 grafts; CABG performed by using the 
following strategies: BITA grafting and RA as third arterial conduit with or without 
additional SV grafts (BITA+RA group) or BITA grafting with additional SV grafts only 
(BITA+SV). In the present series, the RA was considered only in case of target 
stenosis ≥75% and it was used a free graft proximally connected to the ascending 
aorta. The internal thoracic artery was used as a pedicle graft that remained proximally 
connected to its respective subclavian artery (in situ) or as a free graft proximally 
connected to other internal thoracic artery  
Experimental conduits harvesting technique 
During the study period the saphenous vein was exposed by a continuous longitudinal 
incision, the adventitial layer was stripped and side branches ligated. The vein was 
removed from the leg immediately after dissection and was manually gently distended 
using a syringe with heparinised normal saline or by connecting it    to the ascending 
aorta. After distension, the vein was stored in the same fluid use to distend the vein at 
room temperature as previously described [9]. For the RA, if the results of the Allen's 
test were normal in both upper extremities, the monodominant extremity was selected 
and the conduit was harvested with an open technique as previously described [10].  
 
Pre-treatment variables and study end-points  
The effect of adding the RA as third arterial conduit instead of SV was adjusted for the 
following 25 pre-treatment variables including: age, gender, body mass index (BMI); 
Canadian Cardiovascular Society (CCS) grade III or IV; New York Heart Association 
grade III or IV; previous myocardial infarction (MI) and MI within 30 days, previous 
percutaneous coronary intervention (PCI); diabetes mellitus on oral treatment (DM-O) 
or on insulin (DM-I); chronic obstructive pulmonary disease (COPD); hypertension; 
current smoking; serum creatinine ≥200 mmol/l, previous cerebrovascular accident 
(CVA); peripheral vascular disease (PVD); preoperative atrial fibrillation (AF); left main 
disease (LMD); non-LAD vessel diseased including Diagonal (DIA); circumflex (CX); 
right coronary artery (RCA); moderate left ventricle LV dysfunction; severe LV 
dysfunction; non elective priority, off-pump coronary artery bypass (OPCAB) and era 
of surgery (1996-2004 versus 2005-1015).  
The short-term outcomes investigated were: the incidence of re-exploration for 
bleeding, need for sternal reconstruction, postoperative CVA, postoperative renal 
replacement therapy (RRT), need for postoperative intra-aortic balloon pump (IABP) 
and in hospital mortality. Long-term outcome investigated was all-cause late mortality. 
All-cause death is considered the most robust and unbiased index in cardiovascular 
research because no adjudication is required, thus avoiding inaccurate or biased 
documentation and clinical assessments [11]. Information about post-discharge 
mortality tracking was available for all patients (100%) and was obtained by linking the 
institutional database with the National General Register Office.  
Statistical analysis 
For baseline characteristics, variables are summarized as mean for continuous 
variables and proportion for categorical variables. Multiple imputation was used to 
address missing data (http://www.jstatsoft.org/v45/i07/). Information regarding 
baseline creatinine level showed the higher rate of missing information (87/764, 11%) 
(Supplementary Figure 1 and Supplementary Table 1). To control for measured 
potential confounders in the data set, a propensity score (PS) was generated for each 
patient from a multivariable logistic regression model based on pre-treatment 
covariates as independent variables with treatment type (BITA+RA versus BITA+SV) 
as a binary dependent variable (http://CRAN.Rproject.org/package=nonrandom) [12]. 
The resulting propensity score represented the probability of a patient undergoing 
CABG with BITA+RA grafting. Pairs of patients receiving BITA+RA and BITA+SV were 
derived using greedy 1:1 matching with a calliper of width of 0.2 standard deviation of 
the logit of the PS. The quality of the match was assessed by comparing selected pre-
treatment variables in propensity score– matched patient using the standardized mean 
difference (SMD), by which an absolute standardized difference of greater than 10% 
is suggested to represent meaningful covariate imbalance [13]. Analytic methods for 
the estimation of the treatment effect in the matched sample included McNemar’s to 
compare proportions. Kaplan–Meier survival curves between treated and untreated 
subjects in the matched sample were compared using a test described by Klein and 
Moeschberger (http://CRAN.R-project.org/package=survival). As sensitivity analysis, 
to partially address the limited sample size, we performed a time-segmented Cox 
analysis on early (within 30 days) and late mortality (beyond 30 days) by regressing 
the outcome on two independent variables: the treatment assignment (BITA+RA vs 
BITA+SV) and the estimated propensity score [12].  
 
 
 
Results 
The study population included 275 subjects who received BITA grafting with the RA 
as third arterial conduit with (n=41) or without (234) additional SV grafts (BITA+RA 
group) and 489 subjects who received BITA grafting with additional SV graft 
(BITA+SV). Patients characteristics distribution before and after PS matching are 
summarized in Table 1. Patients who received the RA presented a low risk profile. 
In the unmatched group, BITA+SV tended to present a higher burden of comorbidities. 
After matching the two groups were comparable for all pre-treatment variables.  
Intraoperative data 
Grafts target in the unmatched and matched groups are summarized in Table 2. Mean 
number of graft performed were 3.26±0.5 in the BITA+RA group versus 3.33±0.5 and 
3.28±0.5 in the unmatched (P=0.06) and matched (P=0.66) BITA+SV groups 
respectively. The radial artery was used to graft the lateral wall territory in 150 (54%) 
cases and the right coronary system in the remaining 125(45%) cases. Overall, the 
target distribution for the LITA and the RITA was comparable between the two groups.  
Operative outcomes 
Operative outcomes are summarized in Table 3. In hospital mortality occurred in 4 
(0.5%) cases with 1(0.3%) death in the BITA+RA group and 3 (0.6%) deaths in the 
unmatched BITA+SV group (P=1). After matching, the two groups were comparable 
for all operative outcomes investigated. Of note the rate of sternal wound 
reconstruction was particularly low in both groups.  
Long term survival  
The mean follow-up time among survivors was 10.6±4.8 years [max 17.3 years], and 
10.5±4.5 years and 10.5±4.9 in the BITA+RA and BITA+SV groups respectively. In 
the BITA+RA group the survival probability at 5, 10 and 15 years was 97.4±0.9%, 
90.3±2.0% and 81.7±3.2%. In the unmatched BITA+SV group the survival probability 
at 5, 10 and 15 years was 96.8±0.8%, 93.6±0.1% and 83.8±2.5% (log-rank P=0.36 
compared to BITA+SV group). In the matched BITA+SV group the survival probability 
at 5, 10 and 15 years was 97.0±1.0%, 94.1±1.5% and 82.1±3.4% (log-rank P=0.54, 
HR 1.16;95%CI 0.71-1.91 compared to BITA+SV group, Figure 1 left). When the 
analysis was restricted to BITA+RA patients receiving total arterial revascularization 
only by excluding cases with addition SV graft (n=41), the two strategy continued to 
show comparable survival (P=0.34, Figure 1 right). The two strategies showed 
comparable survival probabilities when RAs or SVs were used to graft the right 
coronary system only (P=0.79) or the left coronary system only (P=0.55) (Figure 2) or 
when used in the context of in-situ BITA grafting (P=0.93) or with a free RITA (P=0.30) 
(Figure 3). Time segmented PS adjusted Cox regression models showed that the use 
of the RA did not significantly impact on early (HR 0.29;95% 0.03-2.72;P=0.28) and 
late mortality (HR 1.27;95% 0.79-2.04;P=0.32; Figure 4).  
 
Discussion  
The main finding of the present study is that in a select low risk group of patients 
receiving BITA grafting, the addition of the RA as third arterial conduit was not 
associated with improved long term survival when compared to a matched group of 
patients receiving BITA with additional SV. The lack of survival benefit was present 
when the RA was used to graft both the left and the right coronary systems. In addition, 
when the analysis was restricted to patients receiving total arterial revascularization 
by using BITA and RA without additional SV graft, late survival probabilities remained 
comparable to those observed in subjects receiving BITA and additional SV grafts 
only. Furthermore, BITA+RA and BITA+SV groups showed comparable operative 
outcomes.  
There remains controversy on whether the use of the RA instead of SV in BITA grafting 
is associated with a further improvement in long term outcomes. To date three small 
series have reported on the direct comparison between the RA and SV in addition to 
BITA grafting with conflicting results. Di Mauro et al. [4] reported a survival rate at 8 
years of 91.9±2.9% in 87 patients receiving BITA+RA compared to the 95.6±0.9% in 
patients receiving BITA+SV (P=0.12). More recently Grau et al. [6], recently published 
a series of 183 patients receiving BITA+RA. Long term survival probabilities in 
BITA+RA groups were comparable to those in BITA+SV groups (P=0.25) although 
they observed that at 10 years, the survival curves of the groups crossed and, between 
10 and 14 years, the BITA+RA group demonstrated higher survival (P=0.04). 
However, the phenomenon of crossing survival curves is common when a treatment 
is associated with decreased early survival but may offer long term benefit. The 
observed trend of decreased early survival in patients receiving the RA instead of SV 
is likely to be related to selection bias. In fact the use of the RA per se does not 
increase operative mortality [14] and the RA patency has been demonstrated to be 
non-inferior to SV patency at early angiographic follow-up [15]. Mohammadi et al. [7] 
recently reported comparable long term survival in 249 matched pairs of patients 
receiving BITA+RA versus BITA+SV (P=0.44). However, the main limitation of this 
study is that many of the RA grafts (41.4%) were placed to noncritical coronary targets 
(ie, stenosis 50% to 70%). It is largely demonstrated that the degree of proximal 
stenosis affects RA performance [16,17] and this limitation makes it difficult to interpret 
this findings.  
To the best of our knowledge, the present study is the largest matched series reported 
on the use of RA as third arterial conduit in the context of BITA grafting instead of 
additional SV graft where the RA has been used to graft vessels with ≥75% proximal 
stenosis in all cases thus fulfilling current recommendations for the use of the RA 
[14,15]. We found that the use of the RA did not increase operative risk although we 
found a trend toward a higher rate of re-exploration for bleeding in the BITA+RA 
groups, suggesting the need of extra-attention during haemostasis when using three 
arterial conduits. Of note, the incidence of sternal wound reconstruction observed in 
this series was particularly low thus confirming that in a low risk population (overall 
prevalence of diabetes on insulin ~2%) the use of BITA grafting is safe [18].  
However, long term survival analysis showed that the additional of use of RA in 
this low risk population was not associated with a survival benefit during 15 
years follow-up and this result was found when the RA was used to graft both the 
left and the right coronary systems. Moreover, the RA did not improve survival also in 
cases of total arterial revascularization without additional SV grafts.  
The lack of survival benefit by using the RA as a third graft might be partially explained 
by the determinant role of the two internal thoracic arteries which were likely used to 
graft the two most important myocardial territories with the RA left to grafts the third 
territory in order of clinical significance [19]. In this case the choice of preferring the 
RA over SVG would have limited prognostic implication. Moreover, Hayward et al. [20] 
have previously reported on angiographic follow-up of a limited number of RAs used 
to graft the third and fourth targets in the Radial Artery Patency and Clinical Outcomes 
(RAPCO) study. These were found to have poorer patency rate than vein grafts when 
placed to the third and fourth position thus suggesting the hypothesis that venous 
conduits might be preferable for third and fourth grafts. However this analysis was 
largely underpowered for conclusions to be drawn. Nevertheless, it is well 
demonstrated that the RA patency is largely related to the magnitude of the vascular 
bed for run-off which is influenced not only by the target stenosis degree but also by 
the vessel diameter, diffuseness of disease, left or right dominance and quality of the 
distal arterial bed [16,17,20].  We can speculate that the angiographic superiority of 
the RA over SV might be lost when the RA is used to graft the third target in order of 
expected run-off thus eliminating any potential survival benefit. It can be argued that 
the present study population was highly selected with low burden of comorbidities and 
it does not represent the majority of patients commonly referred for CABG. However, 
a multiple arterial graft strategy is usually adopted in low risk patients with prolonged 
life expectation. In fact its beneficial impact on survival may be delayed by as much 
as a 7 to 10 years but persists beyond that time period; thus, it may be less appreciated 
in older patients with coexistent morbidities and limited life expectancy [21-24]. Of 
note, in the largest randomized trial investigating the impact of using a second arterial 
graft [25], mean age at randomization was 63 years and the prevalence of diabetes 
on insulin was 5.6% only. 
The main limitation of the present study is that no follow-up data were available 
on the cause of death (cardiac versus non-cardiac), recurrence of angina, need 
for repeat revascularization and graft patency to compare the two groups. All-
cause mortality might not be an adequate outcome to assess clinical difference 
in the present highly select low risk patient population.  
As a consequence, the conflicting findings in the literature might be partially 
explained by different patient selection. Moreover, the relatively small sample 
size can partially account for lack of survival benefit by using the RA. However, 
the non-significant trend towards lower survival probabilities in the BITA+RA group, 
also reported by others [4,5] limits the potential role of type beta error in rejecting the 
hypothesis of the superiority of the RA. Finally, the study was observational on 
prospectively collected data and selection bias cannot be excluded despite propensity 
score adjustment.  
In conclusion, we found that long term survival in a highly select group of patients 
receiving BITA grafting was not extended by using the RA as the third arterial 
conduit in preference to SV in patients undergoing first time coronary 
revascularization.   
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Table 1. Pre-treatment variable distribution in the BITA+RA group and in the 
unmatched and matched BITA+SV groups  
 BITA+RA Unmatched 
BITA+SV 
SMD 
 
P Matched 
BITA+SV 
SMD P 
 N=275 N=489   N=275   
 N % n %   n %   
Age (years)      8 0.3   7 0.4 
<60 176 64.0 317 64.8   181 65.8   
60-69 70 25.5 142 29.0   78 28.4   
70-79 28 10.2 26 5.3   12 4.4   
≥80 1 0.4 4 0.8   4 1.5   
Female 18 6.5 29 5.9 3 0.8 16 5.8 3 0.8 
BMI≥30 59 21.5 110 22.5 13 0.08 49 17.8 2 0.8 
CCS III/IV 114 41.5 224 45.8 8 0.3 114 41.5 0 1 
NYHA III/IV 70 25.5 87 17.8 19 0.01 66 24.0 3 0.7 
Past MI 115 41.8 220 45.0 6 0.44 115 41.8 0 1 
MI within 30 days 34 12.4 89 18.2 16 0.04 36 13.1 2 0.9 
Past PCI 6 2.2 23 4.7 14 0.1 5 1.8 3 1 
DM-O 13 4.7 12 2.5 12 0.13 11 4.0 4 0.83 
DM-I 5 1.8 12 2.5 4 0.75 4 1.5 3 1 
Hypertension 171 62.2 317 64.8 5 0.51 177 64.4 5 0.65 
Smoking 47 17.1 77 15.7 4 0.70 49 17.8 2 0.91 
Creatinine≥200mmol 1 0.4 2 0.4 1 1 2 0.7 5 1 
COPD 8 2.9 22 4.5 8 0.37 7 2.5 2 1 
CVA 10 3.6 17 3.5 1 1 11 4.0 2 1 
PVD 17 6.2 24 4.9 6 0.56 16 5.8 2 1 
AF 5 1.8 4 0.8 8 0.38 4 1.5 3 1 
LMD 52 18.9 96 19.6 2 0.8 57 20.7 6 0.7 
Vessel diseased            
CX 262 95.3 460 94.1 5 0.6 265 96.4 4 0.7 
DIA 57 20.7 152 31.1 23 0.003 57 20.7 0 1 
RCA 248 90.2 430 87.9 7 0.4 250 90.9 2 0.9 
LV function            
EF 0.30-0.49 30 10.9 74 15.1 13 0.13 24 8.7 7 0.47 
EF <0.30 3 1.1 6 1.2 1 1 4 1.5 3 1 
Non elective 112 40.7 210 42.9 5 0.6 110 40.0 1 0.9 
Performed by trainee 93 33.8 207 42.3 17 0.02 93 33.8 1 1 
OPCAB 103 37.5 209 42.7 11 0.2 110 40.0 5 0.6 
Year  1996-2005 176 64.0 
 
296 60.5 6 0.3 167 60.7 2 0.7 
          2006-2015 99 36.0 193 39.5   108 39.3   
BITA: Bilateral internal thoracic artery; RA: radial artery; SV: saphenous vein; BMI: 
body mass index; CCS: Canadian Cardiovascular Society; NYHA: New York Heart 
Association; MI: previous myocardial infarction; PCI: percutaneous coronary 
intervention; DM-O: diabetes mellitus on oral treatment; DM-I: diabetes mellitus on 
insulin; COPD: chronic obstructive pulmonary disease; CVA: previous 
cerebrovascular accident; PVD: peripheral vascular disease; AF: preoperative atrial 
fibrillation; LMD: left main disease; DIA: Diagonal; CX: circumflex; RCA: right coronary 
artery; LV: left ventricle; EF: ejection fraction; OPCAB: off-pump coronary artery 
bypass    
Table 2. Grafts target in the BITA+RA group and in the unmatched and matched BITA+SV groups  
 BITA+RA 
N=275 
Unmatched BITA+SV 
N=489 
Matched BITA+SV 
N=275 
RA target CX/DIA = 150 (54%) 
RCA=125(45%) 
 
- - 
SV target CX/DIA=29 (10%) 
RCA=12(4%) 
CX/DIA=293 (60%) 
RCA=217(44%) 
CX+RCA=70 (14%) 
 
CX/DIA=117 (43%) 
RCA=129(47%) 
CX+RCA=26(9%) 
LITA target LAD in situ=199(72%) 
CX/DIA in situ=76(28%) 
LAD in situ=345(71%) 
CX/DIA in situ=144(29%) 
LAD in situ=203(74%) 
CX/DIA=72(26%) 
 
RITA target LAD in situ=70(25%) 
CX/DIA in situ=54 (20%) 
CX/DIA free=38(14%) 
RCA in situ=98(36%) 
RCA free=15(5%) 
LAD in situ=128(26%) 
LAD free=8(2%) 
CX/DIA in situ=162(33%) 
CX/DIA free=66(13%) 
RCA in situ=103(21%) 
RCA free=22(0.5%) 
LAD in situ=64(23%) 
LAD free=3(1%) 
CX/DIA in situ=95(35%) 
CX/DIA free=32(11%) 
RCA in situ=67(24%) 
RCA free=14(6%) 
 BITA: Bilateral internal thoracic artery; RA: radial artery; SV: saphenous vein; LITA: left internal thoracic artery; RITA: right internal 
thoracic artery; LAD: left anterior descending; CX: circumflex artery; DIA: Diagonal; CX: circumflex; RCA: right coronary artery 
 
  
Table 3. Operative outcomes in the BITA+RA group and in the unmatched and matched BITA+SV groups   
 BITA+RA 
 
Unmatched  
BITA+SV 
P 
 
Matched  
BITA+SV 
P 
 N=275 N=489  N=275  
In hospital mortality 1(0.3%) 3(0.6%) 0.64 2(0.7%) 0.56 
Re-exploration for bleeding  12(4.4%) 18(3.7%) 0.64 6(2.2%) 0.15 
Sternal wound reconstruction 1(0.3%) 6(1.2%) 0.22 1(0.4%) 1 
Postoperative cerebrovascular accident 1(0.3%) 8(1.9%) 0.11 6(2.2%) 0.057 
Need for renal replacement therapy 3(1.1%) 7(1.4%) 0.69 4(1.4%) 0.70 
Need for postoperative IABP 3(1.1%) 10(2.0%) 0.32 4(1.4%) 0.70 
BITA: Bilateral internal thoracic artery; RA: radial artery; SV: saphenous vein; IABP: intra-aortic balloon pump
Figure Legend 
Figure 1. Survival curve probabilities comparison between BITA+RA and BITA+SV 
groups in the overall matched samples (left) and using BITA+RA subgroup with total 
arterial revascularization (right) (BITA: Bilateral internal thoracic artery; RA: radial 
artery; SV: saphenous vein) 
Figure 2. Survival curve probabilities comparison between BITA+RA and BITA+SV 
groups according to the third conduit target (BITA: Bilateral internal thoracic artery; 
RA: radial artery; SV: saphenous vein) 
Figure 3. Survival curve probabilities comparison between BITA+RA and BITA+SV 
groups according to BITA configuration (BITA: Bilateral internal thoracic artery; RITA: 
right internal thoracic artery; RA: radial artery; SV: saphenous vein) 
Figure 4. Survival probabilities comparison between BITA+RA and BITA+SV groups 
in a time segmented propensity score adjusted analysis (BITA: Bilateral internal 
thoracic artery; RA: radial artery; SV: saphenous vein) 
 
